Blog

Published on Oct 28, 2025 Share

Discover how Akadeum’s microbubble technology works in just four simple steps that deliver healthier, more potent cells for cell therapy manufacturing. Capable of processing over 50 billion cells in under an hour, Akadeum microbubbles enable gentle, scalable isolation and depletion directly in-bag or within closed systems. Designed for flexibility, microbubbles integrate seamlessly with industry-leading platforms like Cocoon®, Rotea™, Sepax™, and ExPERT GTx™, supporting workflows from research to manufacturing scale. See …

Published on Oct 28, 2025 Share

Akadeum CEO Brandon McNaughton returns to Cell & Gene’s Meeting on the Mesa to present significant regulatory accomplishments, clinical milestones, and recent data from industry collaborators demonstrating how better cell separation is the key to better therapies. Presentation Highlights: Akadeum’s microbubble-based cell separation technology is the first and only separation technology that works entirely “in bag” for untouched, negative selection without the need for magnetics and is compatible with industry-leading …

Published on Oct 21, 2025 Share

Akadeum’s buoyancy-based cell separation allows for an unique in-bag negative selection protocol that can be easily integrated into workflows that already incorporate cell processing equipment, such as the Cytiva Sepax. A Sepax-integrated workflow with Akadeum technology allows for a closed system process that can be scaled to meet any and all manufacturing needs. Utilizing standard Sepax protocols, Akadeum’s Human T Cell Leukopak Isolation Kit – GMP protocol can be initiated …

Updated on Oct 21, 2025 | Published on Oct 14, 2025 Share

Akadeum Life Sciences, the pioneer in gentle buoyant cell separation technology, and BioIVT, a leading global provider of high-quality biological specimens & research services, announce a collaboration aimed at providing healthier T cells via better qualified starting material, for developers and manufacturers of cell therapy products. As cell therapies are complex, the process is important to the success of the product – high-quality starting material is a critical first step …

Published on Oct 2, 2025 Share

Akadeum Life Sciences, a leader in buoyancy-based cell separation technology, will present significant milestone updates of its next-generation cell isolation microbubble technology at the annual Cell & Gene Meeting on the Mesa, taking place October 6–8, 2025, at the historic Arizona Biltmore Resort. Akadeum will also moderate a high-profile Science Slam session with industry leaders on the topic of improving the time and cost to develop therapeutics. On Monday, October 6th, at 4:00 …

Updated on Sep 30, 2025 | Published on Sep 29, 2025 Share

When working with fragile cell types—like stem cells, regulatory T cells, or other rare populations—every extra handling step can make the difference between a healthy, functional sample and one that fails downstream. Processes such as repeated centrifugation, pipetting, or exposure to harsh conditions often introduce unnecessary stress and risk. This article takes a closer look at why minimizing manipulation is so important, the challenges posed by traditional methods, and how …

Updated on Sep 30, 2025 | Published on Sep 29, 2025 Share

The rapid rise of cell therapies is transforming how we treat disease. However, every step from discovery to clinical application must meet rigorous quality and regulatory standards to deliver safe and effective treatments. One critical piece of the workflow is cell separation: isolating or depleting specific immune cell types with precision, speed, and reliability. But as companies advance toward clinical trials and commercialization, not just any kit will do. So …

Published on Sep 29, 2025 Share

Cayman Chemical, a global provider of life science research tools, and Akadeum Life Sciences, a leader in buoyancy-based cell separation technology, announced today a distribution partnership to expand access to Akadeum’s next-generation cell isolation technology for cell and gene therapy development. Under the agreement, Cayman will distribute Akadeum’s portfolio of buoyant microbubble cell isolation kits, integrating this groundbreaking platform into their extensive portfolio of products and services that support life …

Updated on Oct 31, 2025 | Published on Sep 23, 2025 Share

Cells are isolated in-bag then transferred from the bag to any Wilson Wolf G-Rex® bioreactor. Cells are then electroporated using the MaxCyte ExPERT GTx® Instrument. Electroporation can be done at both small and large scale, with the capability of sterile tube welding to facilitate larger scale workflows. Combining technologies, the result is highly viable cells with greater killing potential.

Event Start Date: SEP 23, 2025 Share

The CAR-TCR Summit is the world’s leading conference dedicated to the end-to-end coverage of every stage of cell therapy development. Microbubbles are an effective solution to cell separation challenges in cell therapy and data demonstrating various ways microbubbles are being deployed in cell therapy workflows will be shown at Akadeum’s poster on display beginning the first day of the conference. Akadeum’s team will be onsite, ready to discuss how users …